These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 11174479)
21. P53 codon 72 polymorphism and susceptibility to development of human papilloma virus-associated cervical cancer in Indian women. Nagpal JK; Sahni S; Das BR Eur J Clin Invest; 2002 Dec; 32(12):943-8. PubMed ID: 12534455 [TBL] [Abstract][Full Text] [Related]
22. p53 codon 72 ARG/PRO polymorphism is not related to HPV type or lesion grade in low- and high-grade squamous intra-epithelial lesions and invasive squamous carcinoma of the cervix. Giannoudis A; Graham DA; Southern SA; Herrington CS Int J Cancer; 1999 Sep; 83(1):66-9. PubMed ID: 10449610 [TBL] [Abstract][Full Text] [Related]
23. p53 polymorphism at codon 72--does it constitute a risk for squamous intraepithelial lesions and invasive cancer of the cervix in Central Europeans? Kucera E; Tong D; Reinthaller A; Leodolter S; Zeillinger R; Sliutz G Wien Klin Wochenschr; 2000 Sep; 112(18):817-20. PubMed ID: 11072671 [TBL] [Abstract][Full Text] [Related]
24. The p53 codon 72 genotypes in HPV infection and cervical disease. Abba MC; Villaverde LM; Gómez MA; Dulout FN; Laguens MR; Golijow CD Eur J Obstet Gynecol Reprod Biol; 2003 Jul; 109(1):63-6. PubMed ID: 12818446 [TBL] [Abstract][Full Text] [Related]
25. Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer. Tornesello ML; Duraturo ML; Salatiello I; Buonaguro L; Losito S; Botti G; Stellato G; Greggi S; Piccoli R; Pilotti S; Stefanon B; De Palo G; Franceschi S; Buonaguro FM J Med Virol; 2004 Sep; 74(1):117-26. PubMed ID: 15258977 [TBL] [Abstract][Full Text] [Related]
26. TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies. Klug SJ; Ressing M; Koenig J; Abba MC; Agorastos T; Brenna SM; Ciotti M; Das BR; Del Mistro A; Dybikowska A; Giuliano AR; Gudleviciene Z; Gyllensten U; Haws AL; Helland A; Herrington CS; Hildesheim A; Humbey O; Jee SH; Kim JW; Madeleine MM; Menczer J; Ngan HY; Nishikawa A; Niwa Y; Pegoraro R; Pillai MR; Ranzani G; Rezza G; Rosenthal AN; Roychoudhury S; Saranath D; Schmitt VM; Sengupta S; Settheetham-Ishida W; Shirasawa H; Snijders PJ; Stoler MH; Suárez-Rincón AE; Szarka K; Tachezy R; Ueda M; van der Zee AG; von Knebel Doeberitz M; Wu MT; Yamashita T; Zehbe I; Blettner M Lancet Oncol; 2009 Aug; 10(8):772-84. PubMed ID: 19625214 [TBL] [Abstract][Full Text] [Related]
27. G2 checkpoint in uterine cervical cancer with HPV 16 E6 according to p53 polymorphism and its screening value. Cho NH; Lim SY; Kim YT; Kim D; Kim YS; Kim JW Gynecol Oncol; 2003 Jul; 90(1):15-22. PubMed ID: 12821336 [TBL] [Abstract][Full Text] [Related]
28. p53 status and human papillomavirus infection in Thai women with cervical carcinoma. Limpaiboon T; Pooart J; Bhattarakosol P; Niruthisard S; Chantratita W; Lulitanond V Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):66-71. PubMed ID: 11023067 [TBL] [Abstract][Full Text] [Related]
29. P53 codon 72 and p21 codon 31 polymorphisms and susceptibility to cervical adenocarcinoma in Korean women. Roh JW; Kim BK; Lee CH; Kim J; Chung HH; Kim JW; Park NH; Song YS; Park SY; Kang SB Oncol Res; 2010; 18(9):453-9. PubMed ID: 20524403 [TBL] [Abstract][Full Text] [Related]
30. [Correlation between mutation of p53 gene 2-4 exons from peripheral blood and HPV16 positive cervical cancer susceptibility and clinical significance]. Yin CM; Yao YF; Yan ZL; Yang HY Zhonghua Fu Chan Ke Za Zhi; 2017 May; 52(5):320-326. PubMed ID: 28545270 [No Abstract] [Full Text] [Related]
32. [Polymorphism in codon 72 of the p53 gene and cervico-uterine cancer risk in Mexico]. Suárez-Rincón AE; Morán-Moguel MC; Montoya-Fuentes H; Gallegos-Arreola MP; Sánchez-Corona J Ginecol Obstet Mex; 2002 Jul; 70():344-8. PubMed ID: 12221910 [TBL] [Abstract][Full Text] [Related]
33. TP53, MDM2, NQO1, and susceptibility to cervical cancer. Hu X; Zhang Z; Ma D; Huettner PC; Massad LS; Nguyen L; Borecki I; Rader JS Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):755-61. PubMed ID: 20200430 [TBL] [Abstract][Full Text] [Related]
34. The p53 codon 72 polymorphism in black South African women and the risk of cervical cancer. Pegoraro R; Moodley J; Naiker S; Lanning P; Rom L BJOG; 2000 Sep; 107(9):1164-5. PubMed ID: 11002963 [TBL] [Abstract][Full Text] [Related]
35. The p53 R72P polymorphism does not influence cervical cancer development in a Portuguese population: a study in exfoliated cervical cells. Oliveira S; Sousa H; Santos AM; Pinto D; Pinto-Correia AL; Fontoura D; Moutinho J; Medeiros R J Med Virol; 2008 Mar; 80(3):424-9. PubMed ID: 18205229 [TBL] [Abstract][Full Text] [Related]
36. Polymorphisms in codon 31 of p21 and cervical cancer susceptibility in Korean women. Roh J; Kim M; Kim J; Park N; Song Y; Kang S; Lee H Cancer Lett; 2001 Apr; 165(1):59-62. PubMed ID: 11248419 [TBL] [Abstract][Full Text] [Related]
37. Genetic polymorphism of p53 and XRCC1 in cervical intraepithelial neoplasm in Taiwanese women. Wu MT; Liu CL; Ho CK; Wu TN J Formos Med Assoc; 2004 May; 103(5):337-43. PubMed ID: 15216398 [TBL] [Abstract][Full Text] [Related]
38. p53 polymorphism at codon 72 is not a risk factor for cervical carcinogenesis in central Italy. Cenci M; French D; Pisani T; Alderisio M; Lombardi AM; Marchese R; Colelli F; Vecchione A Anticancer Res; 2003; 23(2B):1385-7. PubMed ID: 12820398 [TBL] [Abstract][Full Text] [Related]
39. Polymorphism in the E6 gene of human papillomavirus type 16 in the cervical tissues of Korean women. Kang S; Jeon YT; Kim JW; Park NH; Song YS; Kang SB; Lee HP Int J Gynecol Cancer; 2005; 15(1):107-12. PubMed ID: 15670304 [TBL] [Abstract][Full Text] [Related]